• C-RAD entered a partnership with SeeTreat to co-develop a connected radiotherapy workflow platform combining SGRT positioning with adaptive decision-support software.
• The companies plan to integrate C-RAD’s Catalyst⁺ HD motion-monitoring platform with SeeTreat’s ART.1 adaptive plan decision support in 2027.
• Collaboration targets faster clinical decisions across radiotherapy departments, including community clinics, regardless of treatment machine type.
• Joint platform will be marketed to clinical teams, with both companies planning to showcase the work at ASTRO 2026 in Boston.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C-RAD AB published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.